ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VEC Vectura Group Plc

164.80
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vectura Group Plc LSE:VEC London Ordinary Share GB00BKM2MW97 ORD 0.0271P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 164.80 164.80 165.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vectura Share Discussion Threads

Showing 7901 to 7924 of 12050 messages
Chat Pages: Latest  326  325  324  323  322  321  320  319  318  317  316  315  Older
DateSubjectAuthorDiscuss
20/11/2018
13:54
alexchry
Always remember i'm usually wrong!!!!!!!!!!!!!!!

pooroldboy55
20/11/2018
11:44
pob55-hope they do get to 70p by Dec 1st, will be buying around 20,000 then to replace the ones I sold at 79p last week.
alexchry
20/11/2018
11:12
dp1umb - sold most at average 700 p in last years and had today only tiny just 5k
It was volatile holding since 2008
Hope you did better.
Anyway its better than nothing.I sold on news today @ 829 p

Hope Woodford’s,other major shareholders and Retail BTG investors cash from BTG sale will be used to increase their holdings in Vectura )))

a1ord53
20/11/2018
10:31
Alord where you still a holder of BTG like a few of us on here ? It was by far my biggest holding by far but I have mixed views on the takeover.
dp1umb
20/11/2018
09:31
Btg being taking over for 840 p cash
by Boston Science - almost 40 % premium

1.Could anybody explain what to expect from court hearing in patent court this week , cause I understood that GSK against Vectura and not Vectura against GSK ?
2. And what to expect in US court VECTURA AGAINST GSK ? BEGIN OF NEXT YEAR ?
Thanks in advance to all :)

a1ord53
20/11/2018
09:30
BTG TAKEN OVER. LET US HOPE VECTURA IS NEXT!
justiceforthemany
19/11/2018
16:39
Only slowly but on our way back to 70p
pooroldboy55
16/11/2018
14:50
alord53 its all a gamble who knows what the share price will do but if your not in you could miss out all part of life, or just don't play the markets and put your money under your bed.
cheers pob

pooroldboy55
16/11/2018
14:17
Above must be in the running for poorest post of the year.
best1467
16/11/2018
11:40
We - shareholders and management are loosers - otherwise we were sold our positions at 180 p
Company is garbage of low income drugs and nothing else .
I am afraid that after lost case next week we will be sold off although this already discounted many times - why not one more time.
So weak company I never hold .

a1ord53
14/11/2018
11:36
Amen to that!
fhmktg
14/11/2018
09:13
pob55-yes, I think we are just waiting for news flow, too many unknowns at the moment. The deal with Hikma was good news but it will be a while before that becomes an income stream. The Advair submission becomes even more important now, if that gets approved next year then we should see a very significant re-rating and about time, I want to be splashing the cash in my retirement and I am relying on Vec to provide plenty of it!
alexchry
14/11/2018
08:47
Don't think anything to do with the market didn't go up when market going well, just trading water waiting for court case and more news flow ,time will tell.
pooroldboy55
14/11/2018
08:40
Look at the overall market!
ianood
14/11/2018
08:39
Drip drip. Somebody wants this down for reasons unclear
insideryou
13/11/2018
12:54
Time frame all in future ..That's also why in think we will drift back down to around 70p, have come off the fence as getting painful.
pooroldboy55
13/11/2018
11:31
Court hearing should be week 19 th of November and will go for 5 days.
BTG and J&J lost patent extention for Zytiga in USA.
In Vec gegen GSK issue is also in patent extention- could anybody explain what court next week should rule/decide ?
Thanks a lot in advance.

PS Anybody can explain why analysts recommendations target prices went down to neutral and hold from buys although we had good results and partnership agreement ???

a1ord53
12/11/2018
10:52
pob55-hope you have a cushion!
alexchry
12/11/2018
10:39
I think there's a chance it( Might ) hows that for sitting on the fence.
pooroldboy55
12/11/2018
08:37
Hi all what's the chances of this being walked back down to 70p during this week ,answers on a postcard please.
pooroldboy55
09/11/2018
15:39
Good volume but struggling to move, looks like there may be a seller/sellers at this level, least we are building a new base.
diesel
09/11/2018
15:06
That EU view on paediatric Fluti should translate eventually to Japan and row sales.The more 'real market' experience Fluti gets the nearer the temptation to review the Canada/US markets.Hikma May come in useful for MENA markets if they haven't been snapped up by Sanofi?
fhmktg
09/11/2018
12:08
Don't think so!! . Lets get above 80p and stay there first.
pooroldboy55
09/11/2018
10:59
Sort I was talking about yesterday’s RNS so this mornings again will hopefully push the shares closer to the £1 mark by year end.
dp1umb
Chat Pages: Latest  326  325  324  323  322  321  320  319  318  317  316  315  Older

Your Recent History

Delayed Upgrade Clock